Ann: Clinical Hold Lifted on PTX-200 Breast Cancer Trial, page-5

I use to post regularly but when into hibernation when the trials were suspended, to concentrate on my other stocks and research new stocks of which their were many.I have still followed the posts and congratulate the L/Termers on their posts.On refreshing myself with the history of PTX and where they are currently this is an outstanding stock and is grossly undervalued and I have looked at a lot of stocks in the intervening period.
So much is going on with such a brilliant team we hope they get the results that are richly deserved.
On listening to the Red Chip video from over a year ago Steve said that the big pharma usually get interested at the end of phase 2 trials and the breast cancer from the reports look very promising from the early intake.The statistics of breast cancer of 1 in 8 Australians getting it with 90% survival after 5 years and of that 25% are HER2. A successful outcome will be very positive for all our other programmes.
Steve said in the latest announcement "We look forward to sharing the final results soon.”I did attempt to ring him to clarify what soon is...perhaps others know...but he was away in the USA.
Anyway I find it is ridiculous that the SP did not go back straightaway to 9c the price at which it was when the trial was suspended...anyway I topped up yesterday with another 400000